Skip to main content
Funding round pulls in $16.8M for Anaconda Biomed

A round of Series A financing brought in approximately $16.8 million for Spanish preclinical stage medical device maker Anaconda Biomed. The proceeds will be used for advancing development of the company's third-generation stented aspiration thrombectomy system, ANCD BRAIN, for treating acute ischemic stroke.

Full Story: